Main Menu
Sponsors

Platinum Sponsors

Gold Sponsors

Silver Sponsors

 


Home > Article

 

Competitive Intelligence: Key Component of Corporate Decision Making
By Cammie Edwards, Ph.D.
DNA Gateway International

Cammie@dnagateway.com

Whether recognized as such or not, companies are always engaged in the process of competitive intelligence. Be it attending professional conferences, reading the competitor’s literature, staying up-to-date on market reports or chatting with friends about trends in the industry, these activities are all part of gathering competitive intelligence. Competitive intelligence (CI) is the process of gathering, analyzing and interpreting external information to guide a company's strategy, planning, and tactical decision-making in commercial operations. For companies to realize the full value of its CI, the information must be complete, analyzed with respect to the company’s needs and disseminated to the key decision-makers. Given the complexities, as well as the potentially long timelines, of developing products in the life science industry, it is particularly important to that life science businesses develop comprehensive competitive intelligence programs that support corporate strategic development and business decisions. Good competitive intelligence will provide full insight into what competitors are currently doing, as well as allowing for the determination of what competitors will do before they do it.

Below is a list of key competitive issues that must be diligently monitored as well as potential sources for obtaining the competitive intelligence1:

1. IP around your competitor’s product(s) and your freedom to operate·
      Carry out a comprehensive patent literature search at least once a year.

2. Market·
      Discuss with your Boards (SAB and corporate) ·
      Network at professional or industry conferences.·
      Talk with KOLs

3. Pricing of your competitor’s product(s) - Allows for competitive valuation of your own deals·
      Talk to competitor sales forces and distributors ·
      Determine standard medicare reimbursement rates for your particular product

4. Stage of development of your competitor’s product(s)·
      Network at professional or industry conferences.

5. Partnerships occurring in your particular area·
      Professional journals, deal databases, professional conferences can provide this info.

6. Valuation of competitor’s companies - Understanding the competitors valuation allows accurate valuation of your own company which is important for funding raising
      Deal databases and networking with VCs can provide insight into value of companies via acquisitions and mergers

7. Emerging technologies and products that could impact your product·
      Discuss with your Scientific Advisory Board ·
      Networking at professional or industry conferences

8. Understanding how your end-user (doctor, life science company, CRO, etc) feels about your competitor’s product(s)
    This allows you to identify weakness you can exploit·
      Directly survey the “end-user”·
      Network at the industry conferences

9. Regulatory and reimbursement issues·
      Determine the current regulatory requirements and identify new issues that might affect the approval, label or marketing of a product

10. Human capital·
      Salary surveys and analyses of job ads can provide important insights into competitors' staffing strategies

As is clear from the list above, networking is a key component of effective CI. Your network contacts can be invaluable for learning about at the smaller deals (i.e. the information that doesn’t make the headlines), emerging products, changes in treatment paradigms, etc. We routinely work with clients to obtain CI in this manner. However, in addition to networks, we use a number of powerful tools, databases and services that can help with the collection of competitive intelligence. In this issue of BioPharma Insight, we invited articles from a range of competitive intelligence service providers and experts to provide their insights into tactics and tools that can assist emerging life science companies with their competitive intelligence acquisition. Recombinant Capital is the premier company providing deal databases. Life Science Consulting, Inc. has built a suite of highly sophisticated tools that analyze complex market, finance and competitor data to facilitate strategic decision making. Taskforce Europe has well-known and proven expertise at assisting companies in CI implementation. Lastly, I.S.I.S. Inc is a recognized leader in providing global competitive intelligence and counterintelligence services to clients over the last 14 years. Obtaining and analyzing CI from a range of sources ensures more accurate and complete competitive information, which is invaluable in assisting with corporate strategy decision making.

1. www.nature.com/bioent/building/planning/032005/full/bioent850.html

Copyright © DNA Gateway International 2008. All Rights Reserved.

 
 
Copyright © 2005-2009 BayAreaBiotechnolgy.com. All Rights Reserved.
Privacy Policy | Terms of Use